Fulgent Genetics (MEX:FLGT) Price-to-Owner-Earnings : (As of Jun. 22, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Fulgent Genetics Price-to-Owner-Earnings?

As of today (2024-06-22), Fulgent Genetics's share price is MXN375.00. Fulgent Genetics does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.

The historical rank and industry rank for Fulgent Genetics's Price-to-Owner-Earnings or its related term are showing as below:

During the past 10 years, the highest Price-to-Owner-Earnings of Fulgent Genetics was 35.97. The lowest was 3.28. And the median was 5.35.

MEX:FLGT's Price-to-Owner-Earnings is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 24.165
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-22), Fulgent Genetics's share price is MXN375.00. Fulgent Genetics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was MXN-95.64. Therefore, Fulgent Genetics's PE Ratio for today is At Loss.

As of today (2024-06-22), Fulgent Genetics's share price is MXN375.00. Fulgent Genetics's EPS without NRI for the trailing twelve months (TTM) ended in was MXN-16.90. Therefore, Fulgent Genetics's PE Ratio without NRI for today is At Loss.

During the past 10 years, Fulgent Genetics's highest PE Ratio without NRI was 475.00. The lowest was 0.00. And the median was 5.45.

Fulgent Genetics Price-to-Owner-Earnings Historical Data

The historical data trend for Fulgent Genetics's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fulgent Genetics Price-to-Owner-Earnings Chart

Fulgent Genetics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Owner-Earnings

Get a 7-Day Free Trial

11.63

6.29

5.46

Fulgent Genetics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Owner-Earnings	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Fulgent Genetics's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, Fulgent Genetics's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fulgent Genetics's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Fulgent Genetics's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Fulgent Genetics's Price-to-Owner-Earnings falls into.

Fulgent Genetics Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Fulgent Genetics's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings	=	Share Price	/	Owner Earnings per Share (TTM)
	=	375.00	/	-83.17
	=

Fulgent Genetics (MEX:FLGT) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.

Fulgent Genetics Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Fulgent Genetics's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.

Fulgent Genetics (MEX:FLGT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fulgent Genetics Inc (MEX:FLGT) » Definitions » Price-to-Owner-Earnings

Comparable Companies

Traded in Other Exchanges

FLGT:USA 7F0:Germany

Address

4978 Santa Anita Avenue, Temple City, CA, USA, 91780

Website

https://www.fulgentgenetics.com

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.